Cumberland Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,679
| Closed | -$325K | – | 189 |
|
|
2025
Q1 | $325K | Sell |
4,679
-25,000
| -84% | -$1.74M | 0.03% | 159 |
|
|
2024
Q4 | $2.55M | Buy |
+29,679
| New | +$2.55M | 0.18% | 85 |
|
|
2024
Q3 | – | Sell |
-149,653
| Closed | -$21.4M | – | 188 |
|
|
2024
Q2 | $21.4M | Sell |
149,653
-4,701
| -3% | -$671K | 1.55% | 25 |
|
|
2024
Q1 | $19.8M | Buy |
154,354
+60,840
| +65% | +$7.81M | 1.44% | 27 |
|
|
2023
Q4 | $8.5M | Sell |
93,514
-250
| -0.3% | -$22.7K | 0.78% | 34 |
|
|
2023
Q3 | $8.53M | Buy |
93,764
+1,400
| +2% | +$127K | 0.82% | 30 |
|
|
2023
Q2 | $7.47M | Buy |
+92,364
| New | +$7.47M | 0.69% | 32 |
|